T1	p 59 67	myositis
T2	p 216 259	44 patients with inclusion body myositis in
T3	i 90 115	methotrexate or placebo .
T4	i 154 182	week oral methotrexate could
T5	i 286 304	placebo-controlled
T6	i 525 537	methotrexate
T7	i 553 560	placebo
T8	i 840 852	methotrexate
T9	i 883 895	methotrexate
T10	o 20 28	weakness
T11	o 339 389	of quantitative muscle strength testing sum scores
T12	o 430 477	Quantitative muscle strength testing sum scores
T13	o 660 747	manual muscle testing sum scores , activity scale scores and patients ' own assessments
T14	o 778 808	Serum creatine kinase activity
T15	o 929 944	muscle weakness
T16	o 959 991	serum creatine kinase activity .